$49.35
-0.35-0.7%
At close: Sep 29, 5:00 PM EST
$49.35
N/A
After Hours: 4:00 PM EST
GSK PLC
GSKNYSE
GSK Earnings & Forecasts
GSK (GSK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GSK Guidance
GSK (GSK) last issued guidance on July 28, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.9 - $5, compared to a consensus EPS estimate of $4.79. GSK also guided revenue in the range of $44.75B - $44.75B for the period.
Compared to prior guidance, GSK maintained its EPS outlook from a previous range of $4.9 - $5. On the revenue side, the company maintained its revenue forecast from a prior range of $44.75B - $44.75B.
GSK has issued 16 guidance updates between November 2, 2022 and July 28, 2026. During this period, the company raised its outlook 6 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.27 | $1.17 | $0.64 | $1.26 |
| Actual | $1.35 | $1.25 | $0.68 | $1.48 |
| Surprise | +6.61% | +6.84% | +6.25% | +17.8% |
| Revenue | ||||
| Estimate | $10.79B | $10.19B | $11.19B | $11.16B |
| Actual | $11.28B | $10.30B | $11.46B | $11.53B |
| Surprise | +4.54% | +1.07% | +2.41% | +3.29% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.45 | $0.76 | $1.27 | $1.35 |
| Revenue | ||||
| Consensus | $11.86B | $12.13B | — | — |
